Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Nakaya, Makoto
and
Ohmori, Kenich
2008.
Aripiprazole treatment for depression in schizoaffective disorder.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 32,
Issue. 8,
p.
2012.
Kim, Dennis H.
Maneen, Matthew J.
and
Stahl, Stephen M.
2009.
Building a Better Antipsychotic: Receptor Targets for the Treatment of Multiple Symptom Dimensions of Schizophrenia.
Neurotherapeutics,
Vol. 6,
Issue. 1,
p.
78.
Fuxe, Kjell
Marcellino, Daniel
Woods, Amina S.
Giuseppina, Leo
Antonelli, Tiziana
Ferraro, Luca
Tanganelli, Sergio
and
Agnati, Luigi F.
2009.
Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia.
Journal of Neural Transmission,
Vol. 116,
Issue. 8,
p.
923.
Kim, Dennis H.
and
Stahl, Stephen M.
2010.
Behavioral Neurobiology of Schizophrenia and Its Treatment.
Vol. 4,
Issue. ,
p.
123.
Elmore, Charles S.
Powell, Mark E.
Xiong, Hui
Wu, Ye
Wang, Lijuan
Saunders, David
and
Urbanek, Rebecca A.
2012.
Preparation of two D2 partial agonists in C‐14 and stable isotope labeled forms.
Journal of Labelled Compounds and Radiopharmaceuticals,
Vol. 55,
Issue. 9,
p.
359.
Rapagnani, Maria Paola
2012.
Safety, Efficacy, and Patient Acceptability of Aripiprazole in the Maintenance Treatment of Bipolar Disorder.
Clinical Medicine Insights: Therapeutics,
Vol. 4,
Issue. ,
p.
CMT.S7388.
Xiong, Hui
Wu, Ye
Lehr, Scott G.
Blackwell, William
Steelman, Gary
Hulsizer, Jim
and
Urbanek, Rebecca A.
2012.
Efficient and scalable synthesis of thiazole fused benzazepine as a D2 partial agonist.
Tetrahedron Letters,
Vol. 53,
Issue. 44,
p.
5833.
Urbanek, Rebecca A.
Xiong, Hui
Wu, Ye
Blackwell, William
Steelman, Gary
Rosamond, Jim
Wesolowski, Steven S.
Campbell, James B.
Zhang, Minli
Brockel, Becky
and
Widzowski, Daniel V.
2013.
Synthesis and SAR of aminothiazole fused benzazepines as selective dopamine D2 partial agonists.
Bioorganic & Medicinal Chemistry Letters,
Vol. 23,
Issue. 2,
p.
543.
Zajdel, Pawel
Partyka, Anna
Marciniec, Krzysztof
Bojarski, Andrzej J
Pawlowski, Maciej
and
Wesolowska, Anna
2014.
Quinoline- and Isoquinoline-Sulfonamide Analogs of Aripiprazole: Novel Antipsychotic Agents?.
Future Medicinal Chemistry,
Vol. 6,
Issue. 1,
p.
57.
Kołaczkowski, Marcin
Marcinkowska, Monika
Bucki, Adam
Śniecikowska, Joanna
Pawłowski, Maciej
Kazek, Grzegorz
Siwek, Agata
Jastrzębska-Więsek, Magdalena
Partyka, Anna
Wasik, Anna
Wesołowska, Anna
Mierzejewski, Paweł
and
Bienkowski, Przemyslaw
2015.
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
European Journal of Medicinal Chemistry,
Vol. 92,
Issue. ,
p.
221.
Oosterhof, Chris A.
Mansari, Mostafa El
Bundgaard, Christoffer
and
Blier, Pierre
2016.
Brexpiprazole Alters Monoaminergic Systems following Repeated Administration: an in Vivo Electrophysiological Study.
International Journal of Neuropsychopharmacology,
Vol. 19,
Issue. 3,
p.
pyv111.
Delcourte, Sarah
Ashby, Charles R.
Rovera, Renaud
Kiss, Béla
Adham, Nika
Farkas, Bence
and
Haddjeri, Nasser
2018.
The novel atypical antipsychotic cariprazine demonstrates dopamine D2 receptor‐dependent partial agonist actions on rat mesencephalic dopamine neuronal activity.
CNS Neuroscience & Therapeutics,
Vol. 24,
Issue. 12,
p.
1129.
Lippi, Matteo
Fanelli, Giuseppe
Fabbri, Chiara
De Ronchi, Diana
and
Serretti, Alessandro
2022.
The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?.
International Clinical Psychopharmacology,
Vol. 37,
Issue. 6,
p.
263.